DayTwo Personalized Nutrition Platform
Microbiome-based personalized nutrition recommendations for metabolic health
Platform · Cloud SaaSCompany source
Company profile
About DayTwo
DayTwo is a precision nutrition company that leverages microbiome science and artificial intelligence to deliver personalized dietary recommendations. The company focuses on helping individuals manage their metabolic health, particularly blood sugar control, through data-driven nutritional guidance. DayTwo's approach combines gut microbiome analysis with advanced machine learning algorithms to predict individual responses to different foods. By analyzing a person's unique microbiome composition, the platform generates tailored meal plans and food recommendations designed to optimize metabolic outcomes. The company's technology is grounded in peer-reviewed research and clinical validation, making it a science-based solution for metabolic health management. DayTwo serves both individual consumers seeking to improve their health outcomes and healthcare organizations looking to provide evidence-based nutrition interventions to their patient populations.
Company description DayTwo official website
Primary marketMetabolic Health & Nutrition
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at DayTwo?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- blood sugar management
- diabetes
- metabolic health
- prediabetes
Who it serves
- consumers
- healthcare organizations
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Evaluating the effectiveness of a sliding window technique in machine learning models for mortality prediction in ICU cardiac arrest patients.International journal of medical informatics · Nov 1, 2024
Unbalanced predatory communities and a lack of microbial degraders characterize the microbiota of a highly sewage-polluted Eastern-Mediterranean stream.FEMS microbiology ecology · May 14, 2024
An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species.Nature communications · Jul 5, 2022
An atlas of robust microbiome associations with phenotypic traits based on large-scale cohorts from two continents.PloS one · Jan 1, 2022
Model of personalized postprandial glycemic response to food developed for an Israeli cohort predicts responses in Midwestern American individuals.The American journal of clinical nutrition · Jul 1, 2019
Assessment of a Personalized Approach to Predicting Postprandial Glycemic Responses to Food Among Individuals Without Diabetes.JAMA network open · Feb 1, 2019
Clinical validation
Clinical-trial records
Personalized Nutrition for Diabetes Type 2NCT03662217 · Sponsor · UNKNOWN
Providing Personally Tailored Dietary Suggestions Using Individual Microbiome and Glycemic Index Response.NCT02945514 · Sponsor · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from DayTwo
Recent articles published on DayTwo's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Metabolic Health & Nutrition
Companies using AI to optimize metabolic health, provide personalized nutrition recommendations, or analyze metabolic responses to food for generally healthy or non-diabetic populations. Emphasizes wellness, performance optimization, and preventive health rather than management of a diagnosed disease.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.